KRONOS HEALTH

Commercialization, Portfolio Optimization, and Operational Partnership: Kronos aims to partner with you to deliver commercially solid growth strategies with deep expertise in Oncology Precision Medicine and Advanced Targeted Therapeutics. Drawing on 2 decades of drug launch and pipeline management strategy, Kronos can support your teams in fractional Commercialization (CCO) and Corporate Strategy (CBO), helping achieve your path to registration, commercialization, or business development goals. Kronos's philosophy is rooted in providing you with measurable ROIs using a keen scientific and commercially focused lens. We work as part of your team and aim to provide you with a strong institutionalized governance model to drive growth. Early Commercial Strategy and Go-to-Market Approach (Preclinical-PhI) or PhII Registration Portfolios: - Clinical Trial Strategy and AI/ML Strategy - Path to Registration Requirements - Reimbursement Infrastructure Requirements - Position and Perspective on Evidentiary Needs - HEOR Perspective and HEOR Approach - Pipeline Go/No Go Support - Investor and Board Presentations Portfolio Management: - Portfolio Optimization (White Spaces Analysis, MOA Mapping and Expansion Strategy) - Indication Prioritization - Initiative Prioritization Workshops / Design Thinking Precision Medicine: - Companion Diagnostic Strategy - Drug-Diagnostics Check-list - Pre-Launch T-48 and T-36 Playbooks and Tracking Dashboards Business Development and Venture Capital Partnerships: Drawing on two decades of global commercial experience in biopharmaceuticals and healthcare, partner with Kronos to apply a commercial lens to enhance early pipeline decisions, founder company growth, and strategic collaborations that differentiate your core value. - Robust Path to Regulatory and Registration Success - Bench-market model Incorporation and Testing - Industry Collaboration Scouting and Support Innovate. Collaborate. Grow